• About Us
    • Our Purpose
    • Our Team
    • Our Culture & Values
    • Our Difference
  • Medicines
    • ACCRUFeR®
    • Publications
  • Patients & HCPs
  • Global Partners
  • Investors
    • Results, Reports & Presentations
    • Regulatory Announcements
      • Regulatory Alerts Sign-up
    • Events
    • Investor News Sign-up
    • Video & Audio
    • Share Price Center
    • Financial Calendar
    • Corporate Governance
    • Analyst Coverage
    • Investor & Advisor Contacts
    • AIM Rule 26
  • News
  • Careers
    • Open Roles
  • Contact
    • Our Purpose

      Our Purpose

      Our clear purpose is to develop medicines that improve the lives of people suffering from iron deficiency, enabling them to enjoy the things that make a difference in their everyday lives.

      Learn more

    • Our Team

      Our Team

      Our achievements would not be possible without the outstanding team that make up Shield Therapeutics’ staff, Senior Executive Team and Board of Directors.

      Learn more

    • Our Culture & Values

      Our Culture & Values

      Our focus is our people, patients, partnerships and medicines to create a working culture founded on our core value.

      Learn more

    • Our Difference

      Our Difference

      Our lead product is approved for the treatment of iron deficiency with or without anemia in adults in the United States, European Union, UK and Switzerland and has exclusive IP rights until the mid 2030s.

      Learn more

    About Us

    About Us

    Delivering innovative specialty pharmaceuticals to address significant unmet needs in the treatment of iron deficiency.

    Learn more

    • ACCRUFeR®

      ACCRUFeR®

      ACCRUFeR® is a stable, non-salt based oral therapy for adults with iron deficiency with or without anemia.

      Learn more

    • Publications

      Publications

      Shield and our collaborators actively publish and present new data. Please find key publications and posters below.

      Learn more

    Medicines

    Medicines

    Shield Therapeutics is a patient-focused, commercial stage pharmaceutical company on a mission to improve the lives of people suffering from iron deficiency, enabling them to enjoy the things that make a difference in their everyday lives.

    Learn more

  • Patients & HCPs

    Patients & HCPs

    Existing treatment options have significant drawbacks and many Health Care Professionals (HCPs) agree there is an unmet need in the market for an effective, convenient and well-tolerated oral iron replacement therapy.

    Learn more

  • Global Partners

    Global Partners

    Collaborating and partnering is key to achieving our global success.

    Learn more

    • Results, Reports & Presentations

      Results, Reports & Presentations

      Browse our library of results, reports and presentations.

      Learn more

      • Regulatory Alerts Sign-up

        Regulatory Alerts Sign-up

        Sign up to Shield Therapeutics plc regulatory news alerts.

        Learn more

      Regulatory Announcements

      Regulatory Announcements

      Latest regulatory announcements from Shield Therapeutics plc.

      Learn more

    • Events

      Events

      We attend a host of investor and scientific events across the world. See details of upcoming events.

      Learn more

    • Investor News Sign-up

      Investor News Sign-up

      Sign up to investor news alerts

      Learn more

    • Video & Audio

      Video & Audio

      See video and audio content from Shield Therapeutics

      Learn more

    • Share Price Center

      Share Price Center

      View our share price information.

      Learn more

    • Financial Calendar

      Financial Calendar

      Financial Calendar

      Learn more

    • Corporate Governance

      Corporate Governance

      As a company whose shares are admitted to trading on AIM, Shield Therapeutics plc is required to comply with the AIM Rules for Companies.

      Learn more

    • Analyst Coverage

      Analyst Coverage

      The following analysts currently issue reports on Shield Therapeutics:

      Learn more

    • Investor & Advisor Contacts

      Investor & Advisor Contacts

      Our investor and advisor contacts should you have a query.

      Learn more

    • AIM Rule 26

      AIM Rule 26

      This information on this page is disclosed in accordance with AIM Rule 26.

      Learn more

    Investors

    Investors

    Welcome to our dedicated investors section.

    Learn more

  • News

    News

    See latest news from Shield Therapeutics plc

    Learn more

    • Open Roles

      Open Roles

      Id volutpat lacus laoreet non leo vel orci porta non pulvinar interdum viverra mauris.

      Learn more

    Careers

    Careers

    As an ambitious and growing pharmaceutical company we are always looking for new talent to join us. Find out more about life at Shield.

    Learn more

  • Contact

    Contact

    Find out how to get in touch with Shield Therapeutics plc

    Learn more

   
1110x680_Investors.jpg

Financial Calendar

  1. Home
  2. Investors
  3. Financial Calendar

20 Jun 2024, 2:00 PM - 3:00 PM

AGM 2024
Add to calendar

28 Sep 2023, 7:00 AM - 29 Sep 2023, 12:00 PM

Interim results for the six months ended 30 June 2023
Add to calendar

28 Jun 2023, 2:00 PM - 3:00 PM

Shield Therapeutics plc Annual General Meeting 2023
Add to calendar

27 Apr 2023

Final results
Add to calendar

08 Sep 2022

Interim Results
Add to calendar

27 Jul 2022

General Meeting 2022
Add to calendar

27 Jul 2022

AGM 2022
Add to calendar

17 Aug 2021

Interim Results
Add to calendar

18 Jun 2021

AGM 2021
Add to calendar

29 Apr 2021

Preliminary Results
Add to calendar

16 Sep 2020

Interim Results
Add to calendar

18 Jun 2020

AGM 2020
Add to calendar

21 May 2020

Preliminary Results
Add to calendar

07 Aug 2019

Interim Results
Add to calendar

13 Jun 2019

AGM 2019
Add to calendar

19 Sep 2018

Interim Results
Add to calendar

28 Jun 2018

AGM 2018
Add to calendar

05 Jun 2018

Annual Results 2017
Add to calendar

03 Apr 2018

Preliminary Results
Add to calendar

Shield Therapeutics plc is registered in England and Wales. Company No. 09761509

  • Sitemap
  • Accessibility
  • Cookie Declaration
  • Privacy Policy
  • Terms & Conditions

Shield Therapeutics plc
Northern Design Centre
Baltic Business Quarter
Gateshead Quays
NE8 3DF
UK

Copyright 2025 Shield Therapeutics plc
Website by Design Portfolio